I am a biotech and pharmaceutical development executive with over 18 years of experience spanning drug development, translational medicine, CMC, and strategic leadership. My background combines senior roles in global pharmaceutical companies, including Teva, with executive leadership in early-stage biotechnology ventures, including Chief Development Officer and acting CEO responsibilities.
I specialize in translating scientific innovation into practical development strategies, assessing technical and regulatory risks, prioritizing pipelines, and building capital-efficient development programs. I have extensive experience leading multidisciplinary teams, managing CROs and external partners, and guiding complex development programs.
I work with biotech companies, investors, and management teams on development strategy, technical due diligence, portfolio decisions, and operational execution, helping bridge the gap between scientific potential and commercial objectives.